Insider Selling: Duolingo, Inc. (NASDAQ:DUOL) Insider Sells 10,000 Shares of Stock

Duolingo, Inc. (NASDAQ:DUOL) insider Severin Hacker sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $223.47, for a total value of $2,234,700.00. Following the completion of the transaction, the insider now directly owns 72 shares of the company’s stock, valued at $16,089.84. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Severin Hacker also recently made the following trade(s):

• On Monday, April 1st, Severin Hacker sold 10,000 shares of Duolingo stock. The shares were sold at an average price of $218.42, for a total value of $2,184,200.00.

Duolingo Stock Up 4.9 %

DUOL stock opened at $240.00 on Friday. The company has a 50 day moving average price of $216.60 and a two-hundred day moving average price of $204.54. The company has a debt-to-equity ratio of 0.03, a quick ratio of 3.24 and a current ratio of 3.24. The stock has a market capitalization of $10.29 billion, a P/E ratio of 705.90 and a beta of 0.82. Duolingo, Inc. has a one year low of $116.82 and a one year high of $245.87.

Duolingo (NASDAQ:DUOL) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.05. The business had revenue of $150.99 million for the quarter, compared to analysts’ expectations of $146.98 million. Duolingo had a return on equity of 2.64% and a net margin of 3.03%. As a group, sell-side analysts expect that Duolingo, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

DUOL has been the subject of several research reports. JPMorgan Chase & Co. assumed coverage on Duolingo in a research note on Monday, March 11th. They set an “overweight” rating and a $270.00 price target for the company. Bank of America lifted their target price on shares of Duolingo from $230.00 to $260.00 and gave the stock a “neutral” rating in a research report on Thursday, February 29th. Barclays raised their price objective on shares of Duolingo from $173.00 to $243.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 29th. The Goldman Sachs Group upped their target price on Duolingo from $160.00 to $190.00 and gave the company a “sell” rating in a research note on Thursday, February 29th. Finally, Needham & Company LLC increased their target price on Duolingo from $210.00 to $241.00 and gave the company a “buy” rating in a report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $245.13.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of DUOL. Discovery Value Fund acquired a new position in Duolingo in the fourth quarter valued at $27,000. FSC Wealth Advisors LLC purchased a new position in shares of Duolingo in the 4th quarter worth about $39,000. Bamco Inc. NY acquired a new position in shares of Duolingo in the 3rd quarter valued at about $39,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of Duolingo in the 4th quarter valued at about $73,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in shares of Duolingo during the 4th quarter worth about $92,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

Duolingo Company Profile

Duolingo, Inc operates as a mobile learning platform in the United States, the United Kingdom, and internationally. The company offers courses in 40 different languages, including Spanish, English, French, German, Italian, Portuguese, Japanese, and Chinese through its Duolingo app. It also provides a digital English language proficiency assessment exam.